ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

GLSI Greenwich LifeSciences Inc

14,01
0,02 (0,14%)
04 Mai 2024 - Fermé
Retardé de 15 minutes

Période:

Mode Dessin:

Volume 35 828
Prix Achat 13,25
Prix Vente 15,00
Actualités -
Maximum Haut 14,64

Bas
7,58

Sur 52 semaines

Haut
21,44

Minimum Bas 13,93
Nom Action Symbole Action Marché Type
Greenwich LifeSciences Inc GLSI NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,02 0,14% 14,01 01:26:02
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
14,17 13,93 14,64 14,39 13,99
Transactions Totales Volume échangé VWAP Volume Financier Volume en moyenne Sur 52 semaines
846 35 828 US$ 14,26 US$ 510 870 - 7,58 - 21,44
Dernière Transaction Type Quantités échangées Prix transaction Devise
01:26:02 formt 360 US$ 14,01 USD

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
184,5M 12,85M - 0 -8,89M -0,69 -
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités Action Greenwich LifeSciences

Date Heure Source Titre
13/3/202411:00GlobeNewswire Inc.Greenwich LifeSciences Extends Lock-up of Directors and..
12/3/202411:00GlobeNewswire Inc.Greenwich LifeSciences Partners with GEICAM in Spain &..
07/3/202415:41Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of..
07/3/202412:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
27/2/202412:00GlobeNewswire Inc.Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial..
22/2/202412:00GlobeNewswire Inc.Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol..
21/2/202412:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:15Edgar (US Regulatory)Form 8-K - Current report
20/2/202412:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:10Edgar (US Regulatory)Form 8-K - Current report
14/2/202412:00GlobeNewswire Inc.Greenwich LifeSciences Provides Update on Phase III Clinical..

Forum Action Greenwich LifeSciences

Aucune Discussion TrouvéeAjouter une Discussion

Historiques Greenwich LifeSciences Inc

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine12,5714,7512,2513,4631 0251,4411,46%
1 mois17,7517,9811,37514,0935 932-3,74-21,07%
3 mois8,6621,448,1514,6655 0755,3561,78%
6 mois8,5421,448,0013,3636 0375,4764,05%
1 an10,9121,447,5812,2626 2313,1028,41%
3 ans38,1648,966,824118,0669 699-24,15-63,29%
5 ans5,00158,073,26236,94162 2119,01180,20%

Dernières Valeurs Consultées

Delayed Upgrade Clock